Fauci says it's 'unlikely' U.S. will get to herd immunity if many Americans refuse to get coronavirus vaccine

The United States may not get to herd immunity if many Americans refuse to get a coronavirus vaccine that's around 70 percent effective, according to Dr. Anthony Fauci.
Fauci, director of the National Institute of Allergy and Infectious Diseases, in an interview with CNN spoke about how effective a COVID-19 vaccine might be, noting that this remains unclear but that he'd "settle" for one being about 70 or 75 percent effective since "that would bring you to that level of what would be herd immunity level." Herd immunity, as the Mayo Clinic explains, "occurs when a large portion of a community (the herd) becomes immune to a disease, making the spread of disease from person to person unlikely."
This prompted a question from CNN's Elizabeth Cohen about whether the U.S. would be able to get to herd immunity if a coronavirus vaccine is about 70 or 75 percent effective like Fauci said and if around a third of Americans refuse to get it.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
"Unlikely," Fauci said.
Cohen pointed to some polls indicating how many Americans either say they wouldn't get a coronavirus vaccine or aren't sure; in a May CNN poll, for example, about a third of respondents said they wouldn't try to get the vaccine.
Fauci in the interview noted it's important to get "people to understand that we're doing everything we can to show that it's safe and that it's effective, and it's for the good of them as individuals and in society to take the vaccine," but given the "anti-science, anti-authority, anti-vaccine feeling among some people in this country," there's "a lot of work to do." Brendan Morrow
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Brendan worked as a culture writer at The Week from 2018 to 2023, covering the entertainment industry, including film reviews, television recaps, awards season, the box office, major movie franchises and Hollywood gossip. He has written about film and television for outlets including Bloody Disgusting, Showbiz Cheat Sheet, Heavy and The Celebrity Cafe.
-
Amazon's 'James Bond' deal could mean a new future for 007
In the Spotlight The franchise was previously owned by the Broccoli family
By Justin Klawans, The Week US Published
-
Why are Republicans suddenly panicking about DOGE?
TODAY'S BIG QUESTION As Trump and Musk take a chainsaw to the federal government, a growing number of Republicans worry that the massive cuts are hitting a little too close to home
By Rafi Schwartz, The Week US Published
-
What is JD Vance's Net Worth?
In Depth The vice president is rich, but not nearly as wealthy as his boss and many of his boss' appointees
By David Faris Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published
-
Bird flu one mutuation from human threat, study finds
Speed Read A Scripps Research Institute study found one genetic tweak of the virus could enable its spread among people
By Peter Weber, The Week US Published
-
Dark chocolate tied to lower diabetes risk
Speed Read The findings were based on the diets of about 192,000 US adults over 34 years
By Peter Weber, The Week US Published